Lv5
1590 积分 2021-06-25 加入
ETV5 reduces androgen receptor expression and induces neural stem–like properties during neuroendocrine prostate cancer development
2小时前
已完结
Lower Testosterone level and metastases-free survival in nmCRPC patients treated with novel antiandrogens: A post-hoc analysis of SPARTAN and ARAMIS
2小时前
求助中
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer
2小时前
已完结
Early changes of PSMA PET expression after initiation of androgen receptor signaling inhibitors in CRPC: an international multicenter retrospective study
2小时前
待确认
Reply to M. Kamrava and F. Montorsi et al
2天前
已关闭
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer
3天前
已完结
Prostate-Specific Membrane Antigen: Gateway to Management of Advanced Prostate Cancer
3天前
已完结
Emerging Theranostics for Prostate Cancer and a Model of Prostate-specific Membrane Antigen Therapy
3天前
已完结
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers
3天前
已完结
Radiotherapy and theranostics: a Lancet Oncology Commission
3天前
已完结
皖公网安备34019202002308
